Voyager Therapeutics, Inc. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • October 28th, 2015 • Voyager Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledOctober 28th, 2015 Company Industry Jurisdiction
VOYAGER THERAPEUTICS, INC. FORM OF OFFICER INDEMNIFICATION AGREEMENTOfficer Indemnification Agreement • October 28th, 2015 • Voyager Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledOctober 28th, 2015 Company Industry JurisdictionThis Indemnification Agreement (this “Agreement”) is made as of by and between Voyager Therapeutics, Inc., a Delaware corporation (the “Company”), and (“Indemnitee”).
VOYAGER THERAPEUTICS, INC. FORM OF DIRECTOR INDEMNIFICATION AGREEMENTDirector Indemnification Agreement • October 28th, 2015 • Voyager Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledOctober 28th, 2015 Company Industry JurisdictionThis Indemnification Agreement (this “Agreement”) is made as of by and between Voyager Therapeutics, Inc., a Delaware corporation (the “Company”), and (“Indemnitee”).
LEASE 45/75 Sidney Street Cambridge, Massachusetts LANDLORDLease • October 28th, 2015 • Voyager Therapeutics, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledOctober 28th, 2015 Company Industry
VOYAGER THERAPEUTICS, INC. SECOND AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT APRIL 10, 2015Investors’ Rights Agreement • October 28th, 2015 • Voyager Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledOctober 28th, 2015 Company Industry JurisdictionTHIS SECOND AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”) is made as of April 10, 2015, by and among Voyager Therapeutics, Inc., a Delaware corporation (the “Company”), and each investor listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor.”